Collaborations & Alliances
-
Breaking News | Collaborations & Alliances | Process Development
Orion, Bayer Enter Global Development Pact
To develop and commercialize ODM-201 to treat prostate cancer06.02.14
-
Breaking News | Collaborations & Alliances
Lilly, QIAGEN In Companion Diagnostics Pact
To develop DNA and RNA biomarker assays in common cancers05.30.14
-
Breaking News | Capsules | Collaborations & Alliances | Solid Dosage / Semi-solids
Novozymes Biopharma Enters VELTIS Technology Pact
To assess the dosing and performance of a subunit antigen vaccine candidate05.29.14
-
Breaking News | Capsules | Collaborations & Alliances | Industry News | Solid Dosage / Semi-solids | Vials
NCCN Receives Boehringer Grant to Study Volasertib
Will evaluate data and define the studies to further characterize safety and efficacy05.23.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Capsules | Collaborations & Alliances | Solid Dosage / Semi-solids | Vials
Reckitt Benckiser, AntiOp in Opioid Overdose Development Pact
To employ AntiOp’s nasal drug delivery expertise05.19.14
-
Breaking News | Collaborations & Alliances | Process Development
Novozymes, ThioLogics In Conjugation Platform Pact
To offer serum-stable drug-albumin conjugation capability05.14.14
-
Breaking News | Collaborations & Alliances | Process Development
Ligand, Omthera Ink Cholesterol Drug R&D Alliance
Will employ Ligand’s LTP Technology to improve lipid-lowering activity05.14.14
-
Breaking News | Collaborations & Alliances | Process Development
BMS, Celldex To Evaluate Immunotherapies Combination
Will conduct Phase 1/2 study of nivolumab and varlilumab05.14.14
-
Breaking News | Collaborations & Alliances | Process Development | Validation
Jubilant Biosys, Orion Enter Pain Management Discovery Pact
Aims to develop drug for unmet needs in pain management05.13.14
-
Breaking News | Collaborations & Alliances | Process Development
Agilent, Seoul University To Establish New Research Center
Will provide drug development from identification through to clinical trial testing05.13.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances
Crown Bioscience, NRCMM In Translational Research Pact
Aims to develop new experimental cancer models05.09.14
-
Breaking News | Collaborations & Alliances | Process Development
Euprotec, Cantab Enter Antibiotics Development Pact
Aims to improve treatments for multi-drug resistant bacterial infections05.07.14
-
Breaking News | Capsules | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development | Scale-up/ Technology Transfer
CMC Biologics, MacroGenics In Process Development Pact
CMC to manufacture oncology product candidate05.06.14
-
Breaking News | Collaborations & Alliances | Process Development
Evotec, Eternygen Enter Metabolic Discovery Pact
Evotec will employ its drug discovery platform to identify a clinical candidate05.06.14
-
Breaking News | Collaborations & Alliances | Process Development
Regeneron, Avalanche Biotech Enter Ophthalmology Pact
Aims to develop gene therapy products for ophthalmologic diseases05.05.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances
Pfizer, Second Genome Enter Obesity Research Pact
Will evaluate the microbiome in metabolic diseases05.02.14
-
Breaking News | Collaborations & Alliances | Process Development
Genzyme, Cleveland Clinic in Academic MS Research Pact
Aims to develop new therapeutic approaches to treat MS05.01.14
